<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04594863</url>
  </required_header>
  <id_info>
    <org_study_id>ZS-2525</org_study_id>
    <nct_id>NCT04594863</nct_id>
  </id_info>
  <brief_title>The Investigation of the Mechanism of Cachexia Occurrence for Patients With Gastrointestinal Cancer</brief_title>
  <official_title>The Investigation of the Mechanism of Cachexia Occurrence for Patients With Gastrointestinal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is going to recruit patients with gastrointestinal cancer, collect clinical data&#xD;
      and peripheral blood sample and possible fat samples. The expression of SIRT-6 in peripheral&#xD;
      blood will be tested and connect with different status of cachexia of the patients. A&#xD;
      mathematical model of the relationship between cachexia classification and SIRT-6 expression&#xD;
      is going to constructed as anticipated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At the start of cancer develop, not all patients with gastrointestinal cancer manifest&#xD;
      cachexia, it may be associated with SIRT-6 expression. This study will collect and test the&#xD;
      peripheral blood sample of patients, use it as an important indicator of the degree of&#xD;
      cachexia, and provide references for clinical drug intervention, prognosis and dietary&#xD;
      intervention for cachexia patients. If possible, fat sample of the patients will be collected&#xD;
      during surgery, and the adipose progenitor cells will be cultured to find the key target&#xD;
      proteins by detecting differences in protein expression, changes in protein modification&#xD;
      levels, and protein interactions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SIRT-6 expression</measure>
    <time_frame>4 months</time_frame>
    <description>SIRT-6 expression tested by ELISA</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cachexia</condition>
  <arm_group>
    <arm_group_label>cachexia</arm_group_label>
    <description>patients suffering from cachexia recently</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no cachexia</arm_group_label>
    <description>patients are not suffering from cachexia recently</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      peripheral blood sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are diagnosed with gastrointestinal cancer for the first time without any&#xD;
        chemotherapy or radiotherapy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age between 18 and 90 years old, unlimited gender;&#xD;
&#xD;
          2. Patients who are diagnosed with gastrointestinal cancer for the first time and are&#xD;
             planning to undergo further treatment;&#xD;
&#xD;
          3. Volunteer to participate and sign the informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Women who are pregnant or lactate;&#xD;
&#xD;
          2. Patients with severe metabolic diseases; combined with cardiac function, liver and&#xD;
             kidney dysfunction, acute myocardial infarction and acute stroke in the past 3 months&#xD;
             , COPD acute onset respiratory failure and other serious medical diseases and patients&#xD;
             who need hormone therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kang Yu</last_name>
    <role>Study Director</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kang Yu, MD</last_name>
    <phone>+8613801130457</phone>
    <email>yuk1997@sina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fang Wang</last_name>
    <phone>+8615201646084</phone>
    <email>yours.fang@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking Union Medical College Hospita</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Kang Yu, MD</last_name>
      <phone>+8613801130457</phone>
      <email>yuk1997@sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Fang Wang, MD, MS</last_name>
      <phone>+8615201646084</phone>
      <email>yours.fang@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014 Nov;14(11):754-62. doi: 10.1038/nrc3829. Epub 2014 Oct 9. Review.</citation>
    <PMID>25291291</PMID>
  </reference>
  <reference>
    <citation>Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012 Aug 8;16(2):153-66. doi: 10.1016/j.cmet.2012.06.011. Epub 2012 Jul 12. Review.</citation>
    <PMID>22795476</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 14, 2020</study_first_submitted>
  <study_first_submitted_qc>October 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>October 14, 2020</last_update_submitted>
  <last_update_submitted_qc>October 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
    <mesh_term>Wasting Syndrome</mesh_term>
    <mesh_term>Cachexia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

